PACS Group President and COO Joshua Jergensen disposes of USD 1.25 million in common shares

PACS Group to present at Oppenheimer Healthcare MedTech & Services Conference

PACS Group Earnings Call Highlights Profitable, Disciplined Growth

PACS Group Appoints Patrick Conway to Board of Directors

PACS Group Inc. Files Initial Beneficial Ownership Statement for Director Patrick Hugh Conway

PACS Group appoints Dr. Patrick Conway to board of directors

Pacs Group, Inc. Appoints DR. Patrick Conway, Md, MSC to Board of Directors

Oppenheimer Adjusts Price Target on PACS Group to $42 From $40, Maintains Outperform Rating

PACS Group Is Maintained at Outperform by Oppenheimer

PACS Group Inc. Files Initial Beneficial Ownership Statement for Chief Compliance Officer Kelly Priegnitz

PACS Group Inc. Files Initial Beneficial Ownership Statement for Chief Human Resources Officer Trent Dean Bingham

Stock Track | PACS Group Soars 5.07% Intraday After RBC Raises Price Target to $52

RBC Raises Price Target on PACS Group to $52 From $47, Keeps Outperform Rating

PACS Group Is Maintained at Outperform by RBC Capital

Truist Securities Adjusts Price Target on PACS Group to $50 From $48, Maintains Buy Rating

Stock Track | PACS Group Plummets 9.52% Intraday on Internal Control Concerns Despite Strong Earnings

Stock Track | PACS Group Plunges 6.02% in Pre-market on Internal Control Concerns Despite Strong Earnings